Clearmind Medicine (CMND) Free Cash Flow (2022 - 2026)
Clearmind Medicine (CMND) posted quarterly Free Cash Flow of -$1.8 million for Q2 2026, down 60.97% year-over-year from -$4.5 million in Q2 2025, and up 15.2% quarter-over-quarter from -$2.1 million in Q1 2026.
Clearmind Medicine (CMND) Free Cash Flow (2022 - 2026) Analysis & Trends
Clearmind Medicine's Free Cash Flow history runs 5 years deep, the most recent figure standing at -$1.8 million for Q2 2026.
- In Q2 2026, Free Cash Flow fell 60.97% year-over-year to -$1.8 million; the TTM figure through Apr 2026 stood at -$6.2 million (down 36.25% YoY), while the FY2025 annual figure was -$4.7 million, up 2.56% from the prior year.
- Free Cash Flow for Q2 2026 stood at -$1.8 million, up from -$2.1 million in the prior quarter.
- The five-year high for Free Cash Flow was -$753168.0 in Q4 2023, with the low at -$3518.6 billion in Q3 2022.
- The 5-year median for Free Cash Flow is -$1.3 million (2025), against an average of -$234.6 billion.
- Peak annual rise in Free Cash Flow reached 100.0% in 2023, while the deepest fall reached 116.26% in 2023.
- Clearmind Medicine's Free Cash Flow stood at -$3518.6 billion in 2022, then surged by 100.0% to -$753168.0 in 2023, then plunged by 43.02% to -$1.1 million in 2024, then fell by 19.37% to -$1.3 million in 2025, then tumbled by 37.51% to -$1.8 million in 2026.
- Business Quant data shows CMND's Free Cash Flow at -$1.8 million in Q2 2026, -$2.1 million in Q1 2026, and -$1.3 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -563.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 437.80 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 292.04 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -95.09 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 477.44 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 433.84 Mn |
| 10 | Clearmind Medicine | 520,887.91 | -13.07 Mn | - | -1.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -1.77 Mn |
| Apr 30, 2026 | -1.77 Mn |
| Jan 31, 2026 | -2.08 Mn |
| Jan 31, 2026 | -2.08 Mn |
| Oct 31, 2025 | -1.29 Mn |
| Oct 31, 2025 | -1.29 Mn |
| Jul 31, 2025 | -1.08 Mn |
| Jul 31, 2025 | -1.08 Mn |
| Apr 30, 2025 | -1.10 Mn |
| Apr 30, 2025 | -1.10 Mn |
| Jan 31, 2025 | -1.27 Mn |
| Jan 31, 2025 | -1.27 Mn |
| Oct 31, 2024 | -1.08 Mn |
| Oct 31, 2024 | -1.08 Mn |
| Jul 31, 2024 | -1.13 Mn |
| Jul 31, 2024 | -1.13 Mn |
| Apr 30, 2024 | -1.19 Mn |
| Apr 30, 2024 | -1.19 Mn |
| Jan 31, 2024 | -1.46 Mn |
| Jan 31, 2024 | -1.46 Mn |